THE AGGRESSIVE CLINICAL COURSE OF A PATIENT WITH BENIGN METASTASISING PLEOMORPHIC ADENOMA OF THE PAROTID GLAND WITHOUT LOCAL RECURRENCE

  • Dr. Fazli Yanik Assistant Professor, Trakya University Faculty of Medicine, Department of Thoracic Surgery, Edirne, Turkey

Abstract

Benign metastasizing pleomorphic adenoma (BMPA) is an extremely rare tumour that is classified histologically. A 58-year-old-woman presented with Pleomorphic adenoma originated from the parotid gland with lung metastasis without local recurrence: There is no effective treatment except total excision and closely monitoring a benign PA with metastasis is important. Herein we report a rare case because several cases with metastasis without local recurrences have been reported in the literature.
Keywords: Metastasizing pleomorphic adenoma, Parotid gland, Surgery.

Downloads

Download data is not yet available.

Author Biography

Dr. Fazli Yanik, Assistant Professor, Trakya University Faculty of Medicine, Department of Thoracic Surgery, Edirne, Turkey

Assistant Professor, Faculty of Medicine

Published
2017-01-30
How to Cite
Dr. Fazli Yanik. (2017). THE AGGRESSIVE CLINICAL COURSE OF A PATIENT WITH BENIGN METASTASISING PLEOMORPHIC ADENOMA OF THE PAROTID GLAND WITHOUT LOCAL RECURRENCE . International Journal of Medical Studies, 2(1), 1-6. Retrieved from http://ijmsonline.in/index.php/ijms/article/view/50
Issue
Vol 2 No 1 (2017): International Journal of Medical Studies (PRINT ISSN 2542:2766)
Section
Articles

Copyright (c) 2017 Author

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The Authors retain copyright (full ownership) to their content published in the Journal. We claim no intellectual property rights over the material provided by any User in this Journal. However, by setting pages to be viewed publicly (Open Access), the User agrees to allow others to view and download the relevant content. In addition, Open Access articles might be used by the Provider, or any other third party, for data mining purposes.

The Provider reserves the rights in its sole discretion to refuse or remove any content that is available via the Website.